Sorbent Therapeutics

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Evaluation of Four Different Dosing Regimens of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Cross-Linked Polyelectrolyte (CLP)
First Posted Date
2014-03-05
Last Posted Date
2014-03-05
Lead Sponsor
Sorbent Therapeutics
Target Recruit Count
25
Registration Number
NCT02079233

Evaluation of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers

First Posted Date
2013-09-17
Last Posted Date
2013-09-17
Lead Sponsor
Sorbent Therapeutics
Target Recruit Count
25
Registration Number
NCT01944007
Locations
🇺🇸

Jasper Clinic, Inc., Kalamazoo, Michigan, United States

Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects

Phase 2
Conditions
Heart Failure
Interventions
Drug: CLP
Drug: placebo
First Posted Date
2012-11-29
Last Posted Date
2014-03-05
Lead Sponsor
Sorbent Therapeutics
Target Recruit Count
270
Registration Number
NCT01736735
Locations
🇺🇸

Orange Country Research Center, Tustin, California, United States

Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease

Phase 1
Completed
Conditions
Heart Failure
Interventions
Drug: CLP
Drug: Spironolactone
First Posted Date
2012-05-15
Last Posted Date
2013-07-19
Lead Sponsor
Sorbent Therapeutics
Target Recruit Count
18
Registration Number
NCT01598740
Locations
🇺🇸

Orange Country Research Center, Tustin, California, United States

Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease

Phase 2
Completed
Conditions
Heart Failure
Interventions
Drug: CLP
Drug: Placebo
First Posted Date
2010-12-23
Last Posted Date
2013-03-13
Lead Sponsor
Sorbent Therapeutics
Target Recruit Count
113
Registration Number
NCT01265524
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy